pk 11195 has been researched along with Hyperplasia in 1 studies
PK-11195 : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 1-(2-chlorophenyl)isoquinoline-3-carboxylic acid with the amino group of sec-butylmethylamine
Hyperplasia: An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gong, Z | 1 |
| Han, Y | 1 |
| Wu, L | 1 |
| Xia, T | 1 |
| Ren, H | 1 |
| Yang, D | 1 |
| Gu, D | 1 |
| Wang, H | 1 |
| Hu, C | 1 |
| He, D | 1 |
| Zhou, L | 1 |
| Zeng, C | 1 |
1 other study available for pk 11195 and Hyperplasia
| Article | Year |
|---|---|
Translocator protein 18 kDa ligand alleviates neointimal hyperplasia in the diabetic rat artery injury model via activating PKG.
Topics: Animals; Benzodiazepinones; Carotid Arteries; Carrier Proteins; Cell Movement; Cell Proliferation; C | 2019 |